FdaApplication
ANDA 216845
Identifiers
- fda_app_no: ANDA216845
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2022-09-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DICLOXACILLIN SODIUM | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE;ORAL |
| DICLOXACILLIN SODIUM | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE;ORAL |
2 products